Funded startups/Gut-Brain-Axis Therapeutics Inc.

Gut-Brain-Axis Therapeutics Inc.

SEC filing

Biotechnology · Tempe, AZ

Form D on EDGAR

Amount raised$2Msold at filing

Total offering$20M$18M still open

Investors in the raise22count reported to the SEC

FiledNov 6, 2025first sale Oct 31, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Alexander B. KhorutsDirector

James B. AdamsExecutive Officer, Director

Michael J. SadowskyDirector

Rosa B. Krajmalnik-BrownDirector

Executive officers, directors and promoters as listed on the Form D.